cagrilintide news 2025 VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes REDEFINE trials advance combination treatment
REDEFINE trials advance combination treatment for weight management ADA Meeting News What is Cagrilintide? GMP Plastic In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Three new phase 3 REIMAGINE studies provide some of the strongest evidence yet for CagriSema (cagrilintide + semaglutide) in type 2 diabetes. REIMAGINE 1 Studied people with early type 2 diabetes
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23


